|
Variables
|
OS
|
RFS
|
|---|
|
HR
|
95 % CI
|
P
|
HR
|
95 % CI
|
P
|
|---|
|
No. of tumor nodules (1 vs ≥2)
|
0.736
|
0.578–0.939
|
0.014*
|
0.753
|
0.588–0.965
|
0.025*
|
|
Venous infiltration (Absent vs Present)
|
0.812
|
0.646–1.022
|
0.076
|
0.796
|
0.632–1.004
|
0.054
|
|
TNM tumor stage (I+II vs III+IV)
|
0.267
|
0.194–0.367
|
<0.001*
|
0.236
|
0.170–0.328
|
<0.001*
|
|
BCORL1 expression (Low vs High)
|
0.660
|
0.509–0.854
|
0.002*
|
0.672
|
0.518–0.872
|
0.003*
|
-
OS overall survival, RFS recurrence-free survival, TNM tumor-node-metastasis, HR hazard ratio, CI confidence interval. *Statistically significant
